Sort   by:  
 Page size 
UnknownYAP/TAZ Signalling in Colorectal Cancer: Lessons from Consensus Molecular Subtypes.
Not available
S-EPMC7692643 | biostudies-literature
UnknownSerotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase C.
Not available
S-EPMC2924006 | biostudies-literature
UnknownThe cellular prion protein is a stress protein secreted by renal tubular cells and a urinary marker of kidney injury.
Not available
S-EPMC7165184 | biostudies-literature
UnknownPrion protein localizes at the ciliary base during neural and cardiovascular development, and its depletion affects α-tubulin post-translational modifications.
Not available
S-EPMC4683536 | biostudies-literature
UnknownIntratumor heterogeneity and cell secretome promote chemotherapy resistance and progression of colorectal cancer.
Not available
S-EPMC10160076 | biostudies-literature
UnknownNegative hyperselection of patients with stage III colon cancer receiving anti-EGFR-based adjuvant treatment.
Not available
S-EPMC12607000 | biostudies-literature
UnknownA novel Chr1-miR-200 driven whole transcriptome signature shapes tumor immune microenvironment and predicts relapse in early-stage lung adenocarcinoma.
Not available
S-EPMC10184345 | biostudies-literature
UnknownA proof of concept for targeting the PrPC - Amyloid β peptide interaction in basal prostate cancer and mesenchymal colon cancer.
Not available
S-EPMC9481457 | biostudies-literature
UnknownPrognostic value of the PrPC-ILK-IDO1 axis in the mesenchymal colorectal cancer subtype.
Not available
S-EPMC8244775 | biostudies-literature
UnknownPrPC controls epithelial-to-mesenchymal transition in EGFR-mutated NSCLC: implications for TKI resistance and patient follow-up.
Not available
S-EPMC11379626 | biostudies-literature
Sort   by:  
 Page size